We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




First-of-Its Kind Metal-Alloy Angioplasty Scoring Sheath Effective in Treatment of Critical Arterial Stenosis

By HospiMedica International staff writers
Posted on 18 Feb 2022

A first-of-its kind metal-alloy angioplasty scoring sheath has been found to be effective in the treatment of critical arterial stenosis. More...

Transit Scientific’s (Park City, UT, USA) XO Score Sheath Platform has been shown to be successful in treating highly-stenosed cardiovascular lesions using low pressure peripheral transluminal angioplasty (PTA). Angioplasty is used throughout the body to dilate stenosed, or narrowed, arteries and veins. Vessels with tough fibrous or calcified lesions and plaque can be difficult to treat and are prone to high rates of recoil, dissection, and restenosis often requiring reintervention.

XO Score is a new type of scoring and cutting technology that enables low-pressure lesion dilatation and vessel prep with a broad range of standard off-the-shelf PTA balloons. The unique one-piece metal-alloy exoskeleton construction adapts to the size, shape and length of the physician selected PTA balloon used inside it.

"Calcified stenotic lesions in the iliac and common femoral arteries can be difficult to treat and often require high pressures of greater than 20 atmospheres (ATM) to dilate them adequately," shared Dr. Richard Saxon of Tri-City Medical Center. "We recently treated multiple calcified lesions in the common iliac and femoral arteries which responded well at low 3 to 4 ATM pressures using the XO Score device."

"This result was encouraging as lower pressure is generally safer for the patient, causing fewer dissections, and potentially less need for additional treatments, including stent placement," continued Dr. Saxon. "I look forward to using the XO Score as there continues to be clinical need for new technologies to effectively revascularize CLI (critical limb ischemia) and limb salvage patients."

Related Links:
Transit Scientific 


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A smartphone application displays a glucose concentration that was measured using the new sensor (Photo courtesy of Chuchu Chen and Yonghao Fu)

Wearable Device for Diabetics Could Replace Continuous Glucose Monitoring Systems

Monitoring blood glucose is essential for people with diabetes to prevent complications and maintain long-term health. Current continuous glucose monitoring systems require needles inserted under the skin,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.